-
Modeling Best Practices of Medically Integrated Pharmacies to Improve Treatment Monitoring and Therapy Adherence in Patients With HR+/HER2- Breast Cancer
04 Feb 2026 05:09 GMT
… , FHOPA
Consultant/Advisory Board: Glaxo Smith Kline, Regeneron
Research Grant: AstraZeneca, Janssen …
-
Celltrion Sets Ambitious Revenue Target of 5.3 Trillion Won This Year
04 Feb 2026 01:07 GMT
… . Adding the revenue from the GlaxoSmithKline (GSK) plant in Maryland, USA …
-
US tariff cut to 18% to boost India’s medical device exports
03 Feb 2026 21:09 GMT
… Vaidheesh, former managing director of GlaxoSmithKline Pharmaceuticals: “The market seems to …
-
CORONA Remedies posts ₹355 cr in Q3 FY26
03 Feb 2026 15:36 GMT
… DX, and Dilo BM from GlaxoSmithKline (GSK).
In December 2025, the …
-
Antimicrobials Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036
03 Feb 2026 11:48 GMT
… this evolution: In November 2025, GlaxoSmithKline (GSK) partnered with the Fleming …
-
Topical Pain Relief Market to Reach US$17.3 Bn by 2033, Growing at 5.2% CAGR: Persistence Market Research
03 Feb 2026 07:03 GMT
… Pharmaceutical Industries, Bayer Healthcare, and GlaxoSmithKline leading the charge. These companies …
-
Global corporates unite to put nature on top of the agenda
03 Feb 2026 06:10 GMT
… nature, including multinationals such as GlaxoSmithKline (GSK), AstraZeneca, Decathlon, and Waitrose …
-
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight
02 Feb 2026 23:22 GMT
… , Takeda Pharmaceuticals, Eli Lilly, BerGenBio, GlaxoSmithKline, Duality Biologics, and others.
Colorectal … key endometrial cancer companies, including GlaxoSmithKline, Merck & Co, AstraZeneca, Karyopharm …
-
Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones
02 Feb 2026 22:51 GMT
… inked deals with include AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, and …
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)
02 Feb 2026 22:02 GMT
… Therapeutics will be acquired by GlaxoSmithKline LLC for $58.00 a …